Institutional investors hold a majority ownership of PRGO through the 85.10% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2017, these large investors purchased a net $7.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 7.3 Million shares of Perrigo Company PLC
TEMPLETON GLOBAL ADVISORS LTD. Bought 4.4 Million shares of Perrigo Company PLC
GREENLIGHT CAPITAL, INC. Bought 827.0 Thousand shares of Perrigo Company PLC